Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

AFG Cicero, A Colletti, G Bajraktari… - Nutrition …, 2017 - academic.oup.com
In recent years, there has been growing interest in the possible use of nutraceuticals to
improve and optimize dyslipidemia control and therapy. Based on the data from available …

Pharmacologically active phytomolecules isolated from traditional antidiabetic plants and their therapeutic role for the management of diabetes mellitus

P Ansari, S Akther, JMA Hannan, V Seidel, NJ Nujat… - Molecules, 2022 - mdpi.com
Diabetes mellitus is a chronic complication that affects people of all ages. The increased
prevalence of diabetes worldwide has led to the development of several synthetic drugs to …

Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review

V Soleimani, PS Delghandi, SA Moallem… - Phytotherapy …, 2019 - Wiley Online Library
Milk thistle (Silybum marianum) is a medicinal plant from the Asteraceae family. Silymarin is
the major constituent of milk thistle extract and is a mixture of some flavonolignans such as …

Role of silymarin in cancer treatment: facts, hypotheses, and questions

T Koltai, L Fliegel - Journal of Evidence-Based Integrative …, 2022 - journals.sagepub.com
The flavonoid silymarin extracted from the seeds of Sylibum marianum is a mixture of 6
flavolignan isomers. The 3 more important isomers are silybin (or silibinin), silydianin, and …

Nutraceutical approach to non-alcoholic fatty liver disease (NAFLD): the available clinical evidence

AFG Cicero, A Colletti, S Bellentani - Nutrients, 2018 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is a clinical condition characterized by lipid
infiltration of the liver, highly prevalent in the general population affecting 25% of adults, with …

[HTML][HTML] Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

M Rizzo, A Colletti, PE Penson, N Katsiki… - Pharmacological …, 2023 - Elsevier
Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting around
10–25% of the general adult population, 15% of children, and even> 50% of individuals who …

Plant-based antidiabetic nanoformulations: the emerging paradigm for effective therapy

S Dewanjee, P Chakraborty, B Mukherjee… - International journal of …, 2020 - mdpi.com
Diabetes mellitus is a life-threatening metabolic syndrome. Over the past few decades, the
incidence of diabetes has climbed exponentially. Several therapeutic approaches have …

Herbal medications in cardiovascular medicine

R Liperoti, DL Vetrano, R Bernabei, G Onder - Journal of the American …, 2017 - jacc.org
Herbal medications are commonly used for clinical purposes, including the treatment of
cardiovascular conditions. Compared with conventional medications, herbal medications do …

Polyphenols: potential anti‐inflammatory agents for treatment of metabolic disorders

F Zamani‐Garmsiri, S Emamgholipour… - Phytotherapy …, 2022 - Wiley Online Library
Ample evidence highlights the potential benefits of polyphenols in health status especially in
obesity‐related metabolic disorders such as insulin resistance, type 2 diabetes, and …

Silymarin: Not just another antioxidant

FC Camini, DC Costa - Journal of basic and clinical physiology and …, 2020 - degruyter.com
Abstract Silymarin (Silybum marianum; SM), popularly known as milk thistle, is an extract
that has been used for many centuries to treat liver diseases. In recent years, several studies …